| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -5.8 | -3.7 |
| EPS (diluted, $ a share) | $-0.40 | $-0.27 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: GLSI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Greenwich LifeSciences, Inc.: key numbers
- Share price
- $18.70Close, Nov 17
- Market cap
- $274M
- Shares outstanding
- 14.68MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.